cp wire

CP Wire Articles

OZ, a global consulting company enhancing customer experiences through digital innovation, recently launched a first-of-its-kind application that brings an augmented reality (AR) environment to... read more

Wed, 04/10/19 - 09:35 am

SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, Provided  the results of its first human study on 4/8/19.

The study was primarily undertaken to show... read more

Mon, 04/8/19 - 09:54 am

Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, updated its S-1 Filing. The company is proposing... read more

Mon, 04/8/19 - 09:40 am
RENNES, FRANCE — DIAFIR, a medical technology company focused on the development, manufacture and sale of innovative diagnostic solutions... read more
Mon, 04/8/19 - 12:18 am

Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) announced on 4/5/19 that Celgene has submitted a Biologics License Application (BLA) for luspatercept, an erythroid... read more

Fri, 04/5/19 - 10:44 am

C3J Therapeutics, Inc. (C3J) a private clinical stage biotechnology company focused on the development of novel targeted antimicrobials based on bacteriophage, today announced that the United... read more

Thu, 04/4/19 - 10:24 am

Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, have signed an agreement to establish a 50/50 joint venture to pioneer... read more

Wed, 04/3/19 - 09:39 am

Just a month ago, Silk Road filed for its IPO with an expected maximum of $86 million. The company just amended the filing with a new expected maximum of $138 million. The company intends to trade... read more

Wed, 04/3/19 - 09:25 am

Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology and life science businesses in the Cambridge ecosystem, has completed a... read more

Mon, 04/1/19 - 09:59 am

Enterome SA  announced on 3/27/19 that it will present data on its innovative microbiome-based approach for the development of therapeutic peptide cancer vaccines for the first time in a poster at... read more

Thu, 03/28/19 - 11:55 am

Genome editing company, Precision BioSciences, raised $126.4 million in its IPO on Wednesday. The company sold 7.9 million shares of stock at a public offering price of $16 per share. When it... read more

Thu, 03/28/19 - 09:39 am

Orasis Pharmaceuticals LTD., a clinical stage pharmaceutical company developing a corrective eye drop for the treatment of presbyopia as an alternative to reading glasses, announced on 3/27/19 the... read more

Wed, 03/27/19 - 09:43 am

NGM Updated its IPO filing to include an estimated price range of  $14 to $16 per share. If all available shares are purchased, the IPO will raise more than $122 Million. The company intends to... read more

Tue, 03/26/19 - 09:30 am

Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced on 3/25/19 that it has closed a $40 million financing with Perceptive Advisors. The new funding will... read more

Mon, 03/25/19 - 09:36 am

Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, announced today it has filed a registration... read more

Fri, 03/22/19 - 09:52 am

Enterome SA announced on 3/20/19 that is has entered into a research and development collaboration with Dana-Farber Cancer Institute (Boston, MA) to evaluate and develop gut microbiome-derived... read more

Thu, 03/21/19 - 01:08 pm

Flagship Pioneering announced on 3/20/19 that it has secured  $824 million  in a new capital pool to support the growth of human health and sustainability companies originated by its Flagship Labs... read more

Thu, 03/21/19 - 12:00 pm


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.